Ignite Creation Date:
2025-12-24 @ 4:11 PM
Ignite Modification Date:
2026-01-05 @ 6:29 PM
Study NCT ID:
NCT05593666
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-18
First Post:
2022-10-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II, Multicentre, Randomized, Two-arm Blinded Study to Assess the Efficacy and Safety of Two LXE408 Regimens for Treatment of Patients With Primary Visceral Leishmaniasis
Sponsor:
Drugs for Neglected Diseases
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-12-27
Start Date Type:
ACTUAL
Primary Completion Date:
2025-04-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2022-10-20
First Submit QC Date:
None
Study First Post Date:
2022-10-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-11
Last Update Post Date:
2025-12-18
Last Update Post Date Type:
ESTIMATED